UPDATE: BTIG Research Initiates Coverage On Nu Skin Enterprises On Multiple Challenges Ahead

In a report published Wednesday, BTIG Research analyst April Scee initiated coverage on

with a Neutral rating. In the report, BTIG Research noted, “China must regain momentum to support growth and sentiment likely to remain negative until distributor levels rise, which will take time. We don't see NUS regaining $1bn in China during projection period. We also worry about innovation after underwhelming launches. Further, model sensitive to inventory issues, which may repeat if launches weak. Initiate with Neutral.” Nu Skin Enterprises closed on Tuesday at $39.28.